Close

Patent granted for tech used in cuff-based blood pressure devices

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

CardieX Limited has announced that its subsidiary ATCOR was granted a new patent by the European Patent Office (EPO) for the company’s SphygmoCor technology used in cuff-based blood pressure devices.

EPO Patent Number EP2566387 further protects the company’s intellectual property in relation to the measurement of a central blood pressure (BP) waveform with cardiovascular features using a brachial cuff. Patent EP2566387 specifically covers non-invasively estimating the heart’s pressure and pressure waveform related to cardiac function and arterial properties using a conventional BP cuff inflated to low pressure. The patent provides a simple tool to clinically diagnose and estimate the risk of heart disease.

Examining officers from the EPO referenced the substantial differences to existing patents when granting the new patent to ATCOR, demonstrating the unique nature of the technology. The granting of the European patent follows similar patents granted in the United States and Japan with the new European patent in force until 2034.

ATCOR currently sells the XCEL central blood pressure device and has a partnership with SunTech Medical for the Oscar 2 ABPM device, which both incorporate ATCOR’s SphygmoCor and brachial cuff technology. The company also recently announced a partnership with Andon for the development

of a home-based BP device with advanced cardiovascular vital signs features.

Latest stories

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back